Study S002675

Association of Fasting GLP-1 Level With the Effect of Linagliptin After an Oral Glucose Tolerance Test in Prediabetes and Type 2 Diabetes Mellitus

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05290506
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: PHASE3
Masking: NONE
Status: COMPLETED
Enrollment: 50
Start: 2020-08-01
Primary completion: 2021-03-01
Lead sponsor: National University of Malaysia
Conditions: PreDiabetes; Type 2 Diabetes
Interventions: DRUG:Dipeptidyl-Peptidase IV Inhibitors
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

change from baseline in glucose after 12-week treatment [baseline to 12 weeks]
change from baseline in HbA1c after 12-week treatment [baseline to 12 weeks]
change from baseline in insulin sensitivity/resistance index after 12-week treatment [baseline to 12 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.